MIT Jameel Clinic

Last updated
MIT Jameel Clinic
Established2018
Field of research
 Artificial intelligence and health
Directors Regina Barzilay
James J. Collins
Dimitris Bertsimas
Chairs
 Dan Huttenlocher
Phil Sharp
Campus Massachusetts Institute of Technology
Affiliations MIT Schwarzman College of Computing
Phil Sharp
Website jclinic.mit.edu

The MIT Abdul Latif Jameel Clinic for Machine Learning in Health (commonly, MIT Jameel Clinic; previously, J-Clinic) is a research center at the Massachusetts Institute of Technology (MIT) in the field of artificial intelligence (AI) and health sciences, including disease detection, drug discovery, and the development of medical devices. The MIT Jameel Clinic also supports the commercialization of solutions through grant funding, and has partnered with pharmaceutical companies, like Takeda and Sanofi, and philanthropies, like Community Jameel and Wellcome Trust, to forge collaborations between research and development functions and MIT researchers. [1] [2]

Contents

Co-founded in 2018 by MIT and Community Jameel, [3] the MIT Jameel Clinic is housed in the MIT Schwarzman College of Computing. The mission of the Jameel Clinic is to "revolutionize the prevention, detection, and treatment of disease", and it describes itself as "the epicenter of AI and healthcare at MIT". [4]

The MIT Jameel Clinic is known for using AI for the discovery of the antibiotics halicin and abaucin, and the development of early cancer detection platforms Mirai for breast cancer, and Sybil for lung cancer.

History

On September 17, 2018, the MIT Jameel Clinic was co-founded by MIT and Community Jameel, an organisation of the Jameel family, owners of the Abdul Latif Jameel business. [5] The launch took place at a signing ceremony at MIT with MIT President L. Rafael Reif, and Fady Jameel and Hassan Jameel, then-presidents of Community Jameel. [3] [6] The MIT Jameel Clinic is the fourth major collaboration between MIT and Community Jameel, after the Abdul Latif Jameel Poverty Action Lab, the MIT Abdul Latif Jameel Water and Food Systems Lab, and the MIT Abdul Latif Jameel World Education Lab. [3]

MIT-Takeda Program

On January 6, 2020, the MIT School of Engineering and Takeda, the pharmaceutical company, announced a new funding program to support research and education in AI and health. The MIT-Takeda Program is housed in the MIT Jameel Clinic. The steering committee for the program is led by Professor Anantha P. Chandrakasan, Dean of the School of Engineering, and Anne Heatherington, senior vice president and head of Data Sciences Institute (DSI) at Takeda. [1] [7] [8]

Discovery of halicin

On February 19, 2020, the MIT Jameel Clinic's faculty leads for AI and life sciences, Professor Regina Barzilay and Professor Jim Collins, published a paper in Cell confirming the discovery—for the first time by deep learning—of halicin, the first new antibiotic compound for 30 years, which kills over 35 powerful bacteria, including antimicrobial-resistant tuberculosis, the superbug C. difficile, and two of the World Health Organization's top-three most deadly bacteria. [9] [10] [11] [12] [13]

AI Cures initiative

In 2020, during the COVID-19 pandemic, the MIT Jameel Clinic launched the AI Cures initiative to apply AI techniques to the discovery of effective therapeutics for the disease, and the development of medical devices. The AI Cures initiative is in partnership with the Patrick J. McGovern Foundation, the Defense Advanced Research Projects Agency (DARPA), and the Walter Reed Army Institute of Research (WRAIR). [14]

In September and October 2020, the MIT Jameel Clinic convened two conferences, on data-driven clinical solutions for COVID-19, and on drug discovery. [15] [16]

Audacious Project award

In June 2020, The Audacious Project (formerly the TED Prize), housed at TED and supported by The Bridgespan Group, selected Professor Collins and an MIT Jameel Clinic team, including Professor Barzilay, for funding. Building on the halicin discovery, the Audacious Project funding will support the MIT Jameel Clinic's response to the antibiotic resistance crisis through the development of new classes of antibiotics to protect patients against some of the world's deadliest bacterial pathogens. [17] [18]

Ragon Institute collaboration

In July 2021, a gift from Mark Schwartz enabled the MIT Jameel Clinic to partner with the Ragon Institute (a collaboration between Massachusetts General Hospital, Harvard University and MIT) and the MIT Schwarzman College of Computing to create a collaborative initiative for AI and immunology. [19]

Jameel Clinic AI Hospital Network

With a GBP 3.5m grant from Wellcome Trust, the MIT Jameel Clinic is teaming up with hospitals around the globe to bring AI into mainstream healthcare. [20] [21] [22] To date, the network has extended to 41 hospitals in 13 countries. [22] In providing free access to AI tools, the Jameel Clinic aims to contribute the expertise of its researchers to empower healthcare systems by accelerating the mainstream usage of AI tools on a global scale. [22]

Discovery of abaucin

On 25 May 2023, the MIT Jameel Clinic's faculty leads for life sciences, Jim Collins, and for AI, Regina Barzilay, and colleagues published a paper in Nature Chemical Biology announcing the deep learning-guided discover of abaucin, an antibiotic targeting Acinetobacter baumannii , one of the WHO's top-three deadliest bacteria in the world. [23] [24] [25]

Faculty and governance

Leadership

The MIT Jameel Clinic leadership comprises three faculty leads:

The faculty leads are supported by the Jameel Clinic staff, and coordinate with the Dean of the MIT Schwarzman College of Computing, Daniel P. Huttenlocher. [26] [27]

Advisory board

The MIT Jameel Clinic is supported by an advisory board, chaired by Professor Phil Sharp, winner of the 1993 Nobel Prize in Physiology or Medicine, Institute Professor, former director of the Koch Institute for Integrative Cancer Research and the McGovern Institute for Brain Research, and co-founder of Biogen. [28]

Other members of the advisory board are:

Former members of the advisory board include:

Related Research Articles

<span class="mw-page-title-main">Takeda Pharmaceutical Company</span> Japanese pharmaceutical company

The Takeda Pharmaceutical Company Limited is a Japanese multinational pharmaceutical company, with partial American and British roots. It is the third largest pharmaceutical company in Asia, behind Sinopharm and Shanghai Pharmaceuticals, and one of the top 20 largest pharmaceutical companies in the world by revenue. The company has over 49,578 employees worldwide and achieved US$19.299 billion in revenue during the 2018 fiscal year. The company is focused on oncology, rare diseases, neuroscience, gastroenterology, plasma-derived therapies and vaccines. Its headquarters is located in Chuo-ku, Osaka, and it has an office in Nihonbashi, Chuo, Tokyo. In January 2012, Fortune Magazine ranked the Takeda Oncology Company as one of the 100 best companies to work for in the United States. As of 2015, Christophe Weber was appointed as the CEO and president of Takeda.

<span class="mw-page-title-main">MIT Computer Science and Artificial Intelligence Laboratory</span> CS and AI Laboratory at MIT (formed by merger in 2003)

Computer Science and Artificial Intelligence Laboratory (CSAIL) is a research institute at the Massachusetts Institute of Technology (MIT) formed by the 2003 merger of the Laboratory for Computer Science (LCS) and the Artificial Intelligence Laboratory. Housed within the Ray and Maria Stata Center, CSAIL is the largest on-campus laboratory as measured by research scope and membership. It is part of the Schwarzman College of Computing but is also overseen by the MIT Vice President of Research.

<span class="mw-page-title-main">Phillip Allen Sharp</span> American geneticist and molecular biologist

Phillip Allen Sharp is an American geneticist and molecular biologist who co-discovered RNA splicing. He shared the 1993 Nobel Prize in Physiology or Medicine with Richard J. Roberts for "the discovery that genes in eukaryotes are not contiguous strings but contain introns, and that the splicing of messenger RNA to delete those introns can occur in different ways, yielding different proteins from the same DNA sequence". He has been selected to receive the 2015 Othmer Gold Medal.

<span class="mw-page-title-main">Massachusetts General Hospital</span> Hospital in Massachusetts, United States

Massachusetts General Hospital is the original and largest teaching hospital of Harvard Medical School, Harvard University located in the West End neighborhood of Boston, Massachusetts. Massachusetts General Hospital houses the world's largest hospital-based research program, the Mass General Research Institute, with an annual research budget of more than $1.2 billion in 2021. It is the third-oldest general hospital in the United States with a patient capacity of 999 beds. Along with Brigham and Women's Hospital, Mass General is a founding member of Mass General Brigham, formerly known as Partners HealthCare, the largest healthcare provider in Massachusetts. It is currently ranked among the best hospitals in the United States by U.S. News & World Report.

<span class="mw-page-title-main">Sanjay Sarma</span> Indian mechanical engineer

Sanjay E. Sarma an Indian mechanical engineer who is the Fred Fort Flowers (1941) and Daniel Fort Flowers (1941) professor of mechanical engineering and the Vice President for Open Learning at Massachusetts Institute of Technology. He is credited with developing many standards and technologies in the commercial RFID industry. Sarma is co-author of The Inversion Factor: How to Thrive in the IOT Economy, along with Linda Bernardi and the late Kenneth Traub. Sarma also serves on the board of the MOOC provider edX as a representative of MIT.

<span class="mw-page-title-main">James J. Collins</span> American bioengineer

James Joseph Collins is an American biomedical engineer and bioengineer who serves as the Termeer Professor of Medical Engineering & Science at the Massachusetts Institute of Technology (MIT), where he is also a director at the MIT Abdul Latif Jameel Clinic for Machine Learning in Health.

<span class="mw-page-title-main">Massachusetts Institute of Technology School of Engineering</span> School at the Massachusetts Institute of Technology

The MIT School of Engineering (SoE) is one of the five schools of the Massachusetts Institute of Technology, located in Cambridge, Massachusetts, United States. SoE has eight academic departments and two interdisciplinary institutes. The School grants SB, MEng, SM, engineer's degrees, and PhD or ScD degrees. As of 2017, the Dean of Engineering is Professor Anantha Chandrakasan. The school is the largest at MIT as measured by undergraduate and graduate enrollments and faculty members.

Phillip Terrence "Terry" Ragon is an American entrepreneur and philanthropist who founded InterSystems and is the current CEO.

<span class="mw-page-title-main">Abdul Latif Jameel Poverty Action Lab</span> Global research center working to reduce poverty

The Abdul Latif Jameel Poverty Action Lab (J-PAL) is a global research center working to reduce poverty by ensuring that policy is informed by scientific evidence. J-PAL conducts randomized impact evaluations to answer critical questions in the fight against poverty, and builds partnerships with governments, NGOs, donors, and others to generate new research, share knowledge, and scale up effective programs.

Amy Nadya Finkelstein is a professor of economics at the Massachusetts Institute of Technology (MIT), the co-director and research associate of the Public Economics Program at the National Bureau of Economic Research, and the co-Scientific Director of J-PAL North America. She was awarded the 2012 John Bates Clark Medal for her contributions to economics. She was elected to the National Academy of Sciences and won a MacArthur "Genius" fellowship in 2018.

Regina Barzilay is an Israeli-American computer scientist. She is a professor at the Massachusetts Institute of Technology and a faculty lead for artificial intelligence at the MIT Jameel Clinic. Her research interests are in natural language processing and applications of deep learning to chemistry and oncology.

<span class="mw-page-title-main">Hassan Jameel</span> Saudi businessman and philanthropist (born 1988)

Hassan Mohammed Abdul Latif Jameel is a Saudi businessman and philanthropist. He is Deputy President and Vice Chairman of Saudi Arabia operations of the family-owned international conglomerate business Abdul Latif Jameel, which, among numerous business operations, has distribution rights to Toyota vehicles in Saudi Arabia and other countries. His philanthropy work promotes health and safety, and assists job-seekers and those in need in Saudi Arabia.

<span class="mw-page-title-main">Anantha P. Chandrakasan</span> American engineer

Anantha P. Chandrakasan is the dean of the School of Engineering and Vannevar Bush Professor of Electrical Engineering and Computer Science at Massachusetts Institute of Technology. He is chair of the MIT Climate and Sustainability Consortium and MIT AI Hardware Program, and co-chair the MIT–IBM Watson AI Lab, the MIT–Takeda Program, and the MIT and Accenture Convergence Initiative for Industry and Technology.

<span class="mw-page-title-main">Squirrel AI</span>

Squirrel AI is a Chinese online education technology company that specializes in intelligent adaptive education. It is one of the first companies offering large scale AI-powered adaptive education solutions in China.

<span class="mw-page-title-main">Halicin</span> Drug and first antibiotic identified by a deep learning algorithm

Halicin (SU-3327) is an experimental drug that acts as an enzyme inhibitor of c-Jun N-terminal kinase (JNK). Originally, it was researched for the treatment of diabetes, but development was discontinued for this application due to poor results in testing. In 2019, this molecule was found by an artificial intelligence (AI) model to show antibiotic properties against a number of bacteria.

The MIT Stephen A. Schwarzman College of Computing is a college at the Massachusetts Institute of Technology (MIT), located in Cambridge, Massachusetts, United States. Announced in 2018 to address the growing applications of computing technology, the college is an Institute-wide academic unit that works alongside MIT's five Schools of Architecture and Planning, Engineering, Humanities, Arts, and Social Sciences, Science, and Management. The college emphasizes artificial intelligence research, interdisciplinary applications of computing, and social and ethical responsibilities of computing. It aims to be an interdisciplinary hub for work in artificial intelligence, computer science, data science, and related fields. Its creation was the first significant change to MIT's academic structure since the early 1950s.

The Abdul Latif Jameel Institute for Disease and Emergency Analytics is a research institute at Imperial College London in the fields of epidemiology, mathematical modelling of infectious diseases and emergencies, environmental health, and health economics. Co-founded in 2019 by Imperial College London and Community Jameel, the Jameel Institute is housed in the School of Public Health, within the college's Faculty of Medicine. The mission of the Jameel Institute is "to combat threats from disease worldwide".

<span class="mw-page-title-main">Abaucin</span> Antibiotic

Abaucin is a compound which has been reported to show useful activity as a narrow-spectrum antibiotic. There is evidence that it is effective against Acinetobacter baumannii, which is one of the three superbugs identified by the World Health Organization as a "critical threat" to humanity. Notably, abaucin was developed with assistance from artificial intelligence by a team led by the MIT Jameel Clinic's faculty lead for life sciences, James J. Collins, and McMaster's Jonathan Stokes. Its mode of action involves inhibiting lipoprotein transport. The compound had previously been reported as an antagonist of the chemokine receptor CCR2, but its antibiotic activity was not discovered during earlier research.

Tavneet Suri is a Kenyan development economist currently serving as the Louis E. Seley Professor of Applied Economics at the MIT Sloan School of Management. She is a member of the executive committee of the Abdul Latif Jameel Poverty Action Lab, and a faculty research associate at the National Bureau of Economic Research. Her research focuses on technology adoption and usage in Sub-Saharan Africa.

Emily Breza is an American development economist currently serving as the Frederic E. Abbe Professor of Economics at Harvard University. She is a board member at the Abdul Latif Jameel Poverty Action Lab, and an affiliated researcher at the International Growth Centre and National Bureau of Economic Research. Breza's primary research interests are in development economics, in particular the interplay between social networks and household finance. She is the recipient of a Sloan Research Fellowship.

References

  1. 1 2 "MIT School of Engineering and Takeda join to advance research in artificial intelligence and health". MIT News | Massachusetts Institute of Technology. Retrieved 2020-11-12.
  2. ↑ "Jameel Clinic teams up with Sanofi on AI and machine learning". Drug Discovery News. Retrieved 2021-01-27.
  3. 1 2 3 "Abdul Latif Jameel Clinic for Machine Learning in Health at MIT aims to revolutionize disease prevention, detection, and treatment". MIT News | Massachusetts Institute of Technology. Retrieved 2020-11-12.
  4. ↑ "Jameel Clinic | AI & Healthcare at MIT". Jameel Clinic. Retrieved 2020-11-12.
  5. ↑ "Community Jameel | Innovating for a better future". Community Jameel | Innovating for a better future. Retrieved 2020-11-12.
  6. ↑ "New Jameel Clinic to harness machine learning tech". Arab News. 2018-09-25. Retrieved 2020-11-12.
  7. ↑ analytica, TOKYO (2020-01-07). "武田薬品とMITがAI研究を推進するプログラムを発表 | 医療とAIのニュース・最新記事 - The Medical AI Times". The AI Times (in Japanese). Retrieved 2020-11-12.
  8. ↑ "MIT, Takeda collaborate on new healthcare AI applications". Healthcare IT News. 2020-01-06. Retrieved 2020-11-12.
  9. ↑ Stokes, Jonathan M.; Yang, Kevin; Swanson, Kyle; Jin, Wengong; Cubillos-Ruiz, Andres; Donghia, Nina M.; MacNair, Craig R.; French, Shawn; Carfrae, Lindsey A.; Bloom-Ackermann, Zohar; Tran, Victoria M. (2020-02-20). "A Deep Learning Approach to Antibiotic Discovery". Cell. 180 (4): 688–702.e13. doi: 10.1016/j.cell.2020.01.021 . ISSN   0092-8674. PMC   8349178 . PMID   32084340.
  10. ↑ "Artificial Intelligence Yields New Antibiotic". The MIT Campaign for a Better World. Retrieved 2020-11-12.
  11. ↑ Murgia, Madhumita (February 20, 2020). "AI discovers antibiotics to treat drug-resistant diseases". Financial Times. Retrieved 12 November 2020.
  12. ↑ "Powerful antibiotic discovered using machine learning for first time". the Guardian. 2020-02-20. Retrieved 2020-11-12.
  13. ↑ Marchant, Jo (2020-02-20). "Powerful antibiotics discovered using AI". Nature. doi:10.1038/d41586-020-00018-3. PMID   33603175. S2CID   214135545.
  14. ↑ "Home". AI Cures. Retrieved 2020-11-12.
  15. ↑ "Events". Jameel Clinic. Retrieved 2020-11-12.
  16. ↑ "AI Cures: data-driven clinical solutions for Covid-19". MIT News | Massachusetts Institute of Technology. Retrieved 2020-11-12.
  17. ↑ "Jim Collins receives funding to harness AI for drug discovery". MIT News | Massachusetts Institute of Technology. Retrieved 2020-11-12.
  18. ↑ 재발행, Plato에 의해. "짐 콜린스, 약물 발견을 위해 AI를 활용하기위한 자금 지원 |" (in Korean). Retrieved 2020-11-12.
  19. ↑ "Supercharging Immunology Research". Ragon Institute of MGH, MIT and Harvard. Retrieved 2021-08-30.
  20. ↑ "222396/Z/21/Z". Wellcome. Retrieved 2023-12-16.
  21. ↑ "The Potential of Artificial Intelligence to Bring Equity in Health Care". MIT for a Better World. Retrieved 2023-12-16.
  22. 1 2 3 "Hospital Network – MIT Jameel Clinic" . Retrieved 2023-12-16.
  23. ↑ Stokes, Jonathan M.; Collins, James J.; Liu, Gary; Catacutan, Denise B.; Rathod, Khushi; Swanson, Kyle; Jin, Wengong; Mohammed, Jody C.; Chiappino-Pepe, Anush; Syed, Saad A.; Fragis, Meghan; Rachwalski, Kenneth; Magolan, Jakob; Surette, Michael G.; Coombes, Brian K.; Jaakola, Tommi; Barzilay, Regina (25 May 2023). "Deep learning-guided discovery of an antibiotic targeting Acinetobacter baumannii". Nature Chemical Biology. 2023. doi:10.1038/s41589-023-01349-8 . Retrieved 28 May 2023.
  24. ↑ Trafton, Anne (25 May 2023). "Using AI, scientists find a drug that could combat drug-resistant infections". MIT News . Retrieved 28 May 2023.
  25. ↑ Gallagher, James (25 May 2023). "New superbug-killing antibiotic discovered using AI". BBC . Retrieved 28 May 2023.
  26. 1 2 "People". Jameel Clinic. Retrieved 2020-11-12.
  27. ↑ "Regina Barzilay, James Collins, and Phil Sharp join leadership of new effort on machine learning in health". MIT News | Massachusetts Institute of Technology. Retrieved 2020-11-12.
  28. ↑ "Phillip A. Sharp". MIT Department of Biology. Retrieved 2020-11-12.
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.